Clinical trials
Coronary Artery Disease trials in Greece with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital of Patras | 5 |
| AHEPA University Hospital | 3 |
| Aristotle University Of Thessaloniki | 3 |
| University of Athens | 3 |
| 424 General Military Hospital | 1 |
| Cardiovascular Research Society, Greece | 1 |
| Centro per la Lotta Contro l'Infarto - Fondazione Onlus | 1 |
| Dimitris Chatzitheodorou | 1 |
| Hippocration General Hospital | 1 |
| Insight Lifetech Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 21 |
| Aortic Valve Disease | 2 |
| Aortic Valve Stenosis | 2 |
| Angina, Stable | 1 |
| Aortic Aneurysm | 1 |
| Arterial Occlusive Diseases | 1 |
| Arthritis, Rheumatoid | 1 |
| Atherosclerosis | 1 |
| Coronary Disease | 1 |
| Diabetes Mellitus, Type 2 | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.